bpc 157 randomized clinical trial human Frontiers Frontiers | Pharmacokinetics, distribution, metabolism,
Description
Combination therapy is evaluated on a case-by-case basis, considering medical history, goals, and response to treatment
Modulation of Growth Factors : BPC-157 influences the activity of growth factors involved in tissue repair, such as vascular endothelial growth factor (VEGF) and transforming growth factor-beta (TGF-)
Peinnequin, A., Mouret, C., Birot, F., Alonso, A., Mathieu, J., Clarenon, D., et al
[DOI] [PubMed] [Google Scholar] 36
Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis
